Rosetta Genomics Ltd (ROSG) Stock Price & Overview
NASDAQ:ROSG
Current stock price
The current stock price of ROSG is 0.43 null. Today ROSG is down by 0%. In the past month the price increased by 22.86%. In the past year, price decreased by -78.06%.
ROSG Key Statistics
- Market Cap
- 2.55M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -9.31
- Dividend Yield
- N/A
ROSG Stock Performance
ROSG Stock Chart
ROSG Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to ROSG. When comparing the yearly performance of all stocks, ROSG is a bad performer in the overall market: 85.1% of all stocks are doing better.
ROSG Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ROSG. ROSG has a bad profitability rating. Also its financial health evaluation is rather negative.
ROSG Earnings
ROSG Forecast & Estimates
ROSG Financial Highlights
Over the last trailing twelve months ROSG reported a non-GAAP Earnings per Share(EPS) of -9.31. The EPS increased by 32.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -190.2% | ||
| ROA | -229.85% | ||
| ROE | -1298.18% | ||
| Debt/Equity | 0 |
ROSG Ownership
About ROSG
Company Profile
Rosetta Genomics is a leader in the field of microRNA. The company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic and therapeutic tools, focusing primarily on cancer and various women's health indications.
Company Info
Rosetta Genomics Ltd
10 PLAUT STREET SCIENCE PARK
REHOVOT L3 76706
CEO: Kenneth A. Berlin
Phone: 972-73-222-0700
Rosetta Genomics Ltd / ROSG FAQ
Can you describe the business of Rosetta Genomics Ltd?
Rosetta Genomics is a leader in the field of microRNA. The company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic and therapeutic tools, focusing primarily on cancer and various women's health indications.
What is the stock price of Rosetta Genomics Ltd today?
The current stock price of ROSG is 0.43 null.
What is the dividend status of Rosetta Genomics Ltd?
ROSG does not pay a dividend.
What is the ChartMill technical and fundamental rating of ROSG stock?
ROSG has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Should I buy ROSG stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ROSG.